NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways.
- DOI
- 10.1038/s41598-020-70392-5
- Published
- 2020 Aug 7
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-020-70392-5,
title = {NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways.},
author = {Avci NG and Ebrahimzadeh-Pustchi S and Akay YM and Esquenazi Y and Tandon N and Zhu JJ and Akay M},
year = {2020},
journal = {Scientific reports},
doi = {10.1038/s41598-020-70392-5},
url = {https://doi.org/10.1038/s41598-020-70392-5}
}RIS
TY - JOUR TI - NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways. AU - Avci NG AU - Ebrahimzadeh-Pustchi S AU - Akay YM AU - Esquenazi Y AU - Tandon N AU - Zhu JJ AU - Akay M PY - 2020 JO - Scientific reports DO - 10.1038/s41598-020-70392-5 UR - https://doi.org/10.1038/s41598-020-70392-5 ER -
APA
NG, A., S, E., YM, A., Y, E., N, T., JJ, Z., & M, A. (2020). NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways.. Scientific reports. https://doi.org/10.1038/s41598-020-70392-5
Source records
- pubmed · retrieved 2026-09-26T22:12:16.337Z